Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Unreal so the Rule 24/60 motion may have jeopardized our chance at the Supreme Court?
Is this what you are saying?
Evaporate was heralded and what was the impact on stock price?
This needs to be in the hands of a BP.....otherwise Prepare-it like the other studies will likely fall on deaf ears. Market has yawned on all subsequent findings post REDUCE-IT.
Merk's new CEO starts July 1 (next week). He is on record discussing M&A. I hope they take Amarin out.
Our stock price is sub $5......pathetic. That tells you all you need to know.
Power of Big Pharma. Hopefully Amarin is paying attention.
I hope the Baker Brothers cue /nudge up a sale......
perhaps to Merck.
Before any launch in Europe is botched.
Got it thanks. So how do you think this plays out?
Yes thanks so much.
It was this post: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162665948
it's interesting that he mentioned the Director had no interest in Europe.
No it was not.
Yet the company remains silent.
https://www.griproom.com/fun/10-signs-your-company-is-about-to-be-acquired
Does anyone recall which poster indicated he bumped into Lars at the annual meeting and was informed go it alone in Europe was never the plan.
Was trying to recall which post / poster this was.
Great post. I would love to know what do the Bakers Brothers think and are doing about Amarin right about now.
They can't be too happy with JT & the Board.
how do you see things playing out?
There's some some buying of calls on the Aug 20th and Sept. 17th $5 and $6. Some good volume today
LBL please tell us our spirits being lifted was predicated on something other than Supreme Court.....?
Can you post the link?
Interesting...you think there will be a leak?
If they can penetrate the Supreme Court to find out ahead of everyone that is brazen.
I wonder if there will be a "leak" on Friday regarding the decision at the conference Thursday?
hmmmmm
What do you think they know?
He is a skilled litigator he is used to handling multiple cases.
I only mention it as he will have 2 cases discussed this Thursday at the conference.
The Abbvie case is against the FTC (US Government) tho so perhaps that one gets denied cert.
It's just our bad luck that Seth Waxman is also the attorney on another petition that is also being considered on Thursday.
https://www.supremecourt.gov/search.aspx?filename=/docket/docketfiles/html/public/20-1293.html
Not sure of the chances that both will be granted.....
yea but waiting till end of year just further erodes whatever is left on the usa sales efforts.....it will take any acquirer time to ramp up in USA and it starts to erode time in Europe as well.
post SC decision.....what's the point of continued waiting....
and let's not even consider potential cap gains increases...
hopefully the powers that be realize time is of the essence.
i imagine the Baker Brothers want to see this come to an end soon as well.
I hope any BO is before the end of the year.
Deals take time (months) to close.
Great post thanks for sharing that link. None of the others have amicus briefs.
One other case though does have Paul Clement as the Petitioner. He also has a great track record in getting cases granted cert.
Fingers crossed.
Hopefully the public health implications carry the day for us.
If you believe in prayer.....pray.
You should take a look at Waxman's reply brief:
This is what he is asking for he also cites instances where this was done before
"There is nothing objectionable about Amarin’s “va-cate and remand” request either. In the event the Court determines that the lack of a Federal Circuit opinion somehow presents an obstacle to granting re-view, the Court should vacate and remand with instruc-tions on Graham’s totality framework. Pet. 31. That alternative request is no more “micromanagement” (Opp. 19) than what this Court has done in prior cases. Pet. 31(citing cases)."
While a cert grant would be great (grand slam), I think Waxman did a great job of saying at a minimum remand the case with proper instructions....a middle ground (a base hit).
Fingers crossed.
The public health implications could carry the day for us with a remand. The brief from Aimed Alliance was really good.
Waxman is the go to guy for patent issues so if he is saying you need to take a look at this.....they very well may
We just need a base hit right now.
Power of Big Pharma. SMH
If the case returns to Judge Du, a settlement would be ideal but do you think the parties could reach settlement? I worry about it having become personal / both sides entrenched in their positions.
A settlement would be the best outcome.
The reality is this confirms there is limited supply.
The second thing is that the generics are not legally entitled to the CV market, which is the bulk of the supply. It's absurd. They are complaining about not having access to supply.....which they really want to serve the bulk of the CV market.
Correct Waxman is giving the SC a middle ground if they decide not to take the case he is saying at a minimum remand this case so the proper legal framework can be applied (Graham). It is a good strategy because it allows the SC to still do something if they decide not to take the case up.
His opening directly hits at the public policy implications of stifling innovation via research and development and how much Amarin invested in Vascepa....it is telling the SC hey you really need to look at what happened here. He also draws reference to the amicus briefs.
The SC knows Waxman is the expert on patent litigation. Fingers crossed.
KSR case: https://www.supremecourt.gov/opinions/06pdf/04-1350.pdf
For those interested in reading it. Seth Waxman nailed it when he mentioned that secondary considerations (objective indica) were not what KSR was about as Hikma's lawyers tried to present in their brief.
Read KSR then do a search for KSR in Hikma's brief and then in Amarin's reply brief. Amazing how Hikma's lawyers tried to stretch the truth here by saying the court looked to secondary considerations to rebut. KSR had nothing to do with the the prima facie framework as Hikma's lawyers try to suggest.
Just unreal.
Only till she issues her decision reaffirming her original thoughts re: Amarin's patents.
Fool me once shame on you, fool me twice shame on me
LOL
If this case gets remanded to Judge Du, why not just sell upon the remand decision?
What is the rationale for holding this stock if it goes back to Judge Du?
Do we really expect her to change her mind. Judges don't change their views.
Got it, thanks so much! I see they have some impressive bio investors: Perceptive & Baker Brothers.
May be worth owning both of these companies. SNPXD and ATHA
Have you looked at Athira?
https://investors.athira.com/
The article mentions they are also working on synaptic connections.
Although Athira's market cap is $700 mm.
Welp it's telling he is "retiring."
Baker Bros still hold 26.5 mm shares. I wonder if they had anything to do with his retirement.
I agree. SC saying yes or no to take the case gets the ball moving here. That decision can't come fast enough.
So you believe BO is imminent as in this year?
I believe he has 10 days to respond but I imagine he is probably working fast to respond sooner to make sure that this is before the SC before it breaks for the summer at the end of June.
JMO
I agree. It is hard to get cert. granted.
Pretty much relying on Seth Waxman at this point to convince the Supreme Court to take a look. It is not impossible but don't bank on it. Just the reality.
It is unfortunate we are in this situation but hey you don't try a case in the 9th circuit. SMH